HemaSphere
(Aug 2023)
S177: JAK INHIBITION AND COMBINATION THERAPY IN THE TREATMENT OF MURINE BONE MARROW FAILURE
- Xingmin Feng,
- Jibran Durrani,
- Ash Lee Manley,
- Wu Zhijie,
- Nidhi Aggarwal,
- Jichun Chen,
- Emma Groarke,
- Young Neal
Affiliations
- Xingmin Feng
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Jibran Durrani
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Ash Lee Manley
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Wu Zhijie
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Nidhi Aggarwal
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Jichun Chen
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Emma Groarke
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- Young Neal
- 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000967620.62885.50
- Journal volume & issue
-
Vol. 7
p.
e6288550
WeChat QR code